Trade CRIS anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Curis, Inc. (CRIS) is trading at US$1.51, up 0.33% today as of Aug 28, 12:11 EDT. The company has a market capitalisation of US$3.83M. Over the past 52 weeks, CRIS has traded between US$1.40 and US$39.00. On Syfe you can trade CRIS with $0 commission and add it to your watchlist.
| Previous close | US$1.50 |
|---|---|
| Market cap | US$3.83M |
| 52-week range | US$1.40 – US$39.00 |
| Volume | 287.35K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Curis, Inc.
Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170 and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. The CA-170 pipeline is an also an orally-available small molecule antagonist of PD-L1 and VISTA immune checkpoints. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.
Year: 2000
Curis Consents 6 Patients in Phase 2 Trial of Emavusertib in Chronic Lymphocytic Leukemia
Jul 6, 2:11 PM · MT Newswires
Curis, Inc. (CRIS) stock is trading at US$1.51, +0.33% from the previous close of US$1.50.
The market cap for Curis, Inc. (CRIS) stock is approximately US$3.83M.
The 52-week high for Curis, Inc. (CRIS) stock is US$39.00.
The 52-week low for Curis, Inc. (CRIS) stock is US$1.40.
Curis, Inc. (CRIS) does not currently pay a dividend.
Stay on top of CRIS
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
